OncoCyte (NYSEAMERICAN:OCX) is scheduled to release its earnings data on Monday, February 26th. Analysts expect OncoCyte to post earnings of ($0.13) per share for the quarter.
Shares of OncoCyte (NYSEAMERICAN:OCX) opened at $3.55 on Monday. OncoCyte has a twelve month low of $3.30 and a twelve month high of $7.85. The firm has a market capitalization of $111.57 and a P/E ratio of -5.73.
Separately, Zacks Investment Research upgraded OncoCyte from a “hold” rating to a “buy” rating and set a $4.75 price target for the company in a report on Saturday, January 13th.
WARNING: This piece was first published by Community Financial News and is the property of of Community Financial News. If you are reading this piece on another domain, it was copied illegally and reposted in violation of United States & international copyright and trademark laws. The legal version of this piece can be accessed at https://www.com-unik.info/2018/02/19/oncocyte-ocx-set-to-announce-earnings-on-monday.html.
OncoCyte Corporation is a development-stage biotechnology company focused in the field of regenerative medicine. The Company is developing molecular cancer diagnostics utilizing a discovery platform that focuses on identifying genetic markers expressed in various types of cancer. It operates through the research and development of diagnostic tests for the detection of cancer segment.
Receive News & Ratings for OncoCyte Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OncoCyte and related companies with MarketBeat.com's FREE daily email newsletter.